BriaCell Therapeutics Corp.
BCTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001610820
No open-market purchases or sales by BriaCell Therapeutics Corp. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $1.58M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in BriaCell Therapeutics Corp. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- 0 vs. Q2 2023
- Shares held
- 2.71M
- −67.5K (−2.4%) vs. Q2 2023
- Total value
- $17.0M
- −$860.9K (−4.8%) vs. Q2 2023
- New holders
- 3
- 7 more added
- Sold out
- 3
- 5 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 19 | $1.58M |
| Q1 2026 | 16 | $1.62M |
| Q4 2025 | 13 | $69.2K |
| Q3 2025 | 13 | $136.5K |
| Q2 2025 | 16 | $181.1K |
| Q1 2025 | 14 | $94.1K |
| Q4 2024 | 26 | $379.1K |
| Q3 2024 | 22 | $538.1K |
| Q2 2024 | 20 | $452.0K |
| Q1 2024 | 20 | $6.38M |
| Q4 2023 | 26 | $14.6M |
| Q3 2023 | 21 | $17.0M |
| Q2 2023 | 21 | $17.9M |
| Q1 2023 | 21 | $19.4M |
| Q4 2022 | 21 | $12.3M |
| Q3 2022 | 22 | $14.3M |
| Q2 2022 | 22 | $17.0M |
| Q1 2022 | 18 | $33.5M |
| Q4 2021 | 20 | $10.9M |
| Q3 2021 | 21 | $4.77M |
| Q2 2021 | 24 | $20.3M |
| Q1 2021 | 10 | $1.45M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding BriaCell Therapeutics Corp.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Rosenberg Matthew Hamilton | 12 | $75 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 32 | $200 | 0.00% | 00.0% | Unchanged |
| Toronto Dominion Bank | 33 | $206 | 0.00% | +33 | New |
| Tower Research Capital LLC (TRC) | 528 | $3.30K | 0.00% | −861−62.0% | Reduced |
| National Bank of Canada | 2,500 | $14.9K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 3,600 | $23.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 10,200 | $64.0K | 0.00% | +10,200 | New |
| Concord Wealth Partners | 10,775 | $67.3K | 0.01% | −4,500−29.5% | Reduced |
| TD Waterhouse Canada Inc. | 12,050 | $90.6K | 0.00% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 15,887 | $99.0K | 0.00% | −200−1.2% | Reduced |
| Bank of America Corp | 17,662 | $110.4K | 0.00% | +16,535+1,467.2% | Added |
| K2 Principal Fund, L.P. | 24,969 | $156.1K | 0.05% | +24,969 | New |
| Summit Trail Advisors, LLC | 35,000 | $218.8K | 0.01% | 00.0% | Unchanged |
| Bank of Montreal | 37,629 | $265.4K | 0.00% | +3,000+8.7% | Added |
| Susquehanna International Group, LLP | 52,067 | $325.4K | 0.00% | +33,202+176.0% | Added |
| K.J. Harrison & Partners Inc | 66,090 | $411.1K | 0.09% | +31,450+90.8% | Added |
| Morgan Stanley | 95,015 | $593.8K | 0.00% | +19,787+26.3% | Added |
| Natixis | 95,581 | $597.4K | 0.00% | +5,331+5.9% | Added |
| Redmond Asset Management, LLC | 137,839 | $861.5K | 0.31% | +150+0.1% | Added |
| Wasatch Advisors Inc | 513,761 | $3.21M | 0.02% | −98,327−16.1% | Reduced |
| Lynwood Capital Management Inc. | 1,582,450 | $9.89M | 26.01% | −1,428−0.1% | Reduced |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −63,650−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −39,521−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −3,688−100.0% | Sold out |